These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1929638

  • 1. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
    Parenteau GL, Clark RE.
    Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS, Clement P, Sheridan AQ, Soryal I, Fairfax AJ, Holgate ST.
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD, Bui TC, Bewtra AK, Townley RG.
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [Abstract] [Full Text] [Related]

  • 9. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
    Ungerer RG, Tashkin DP, Siegel SC, Deutsch RI.
    J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
    [Abstract] [Full Text] [Related]

  • 10. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
    Humphreys RA, Kane KA, Parratt JR.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, Bucci MG.
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG, Sheridan AQ.
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
    Ollier S, Graham VA, Bentley S, Davies RJ.
    Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ.
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.